The conclusion was that elevated PAI-1 levels appear to be associated with incident type 2 diabetes independently of established diabetes risk factors, and that there is a need for investigation of the role of PAI-1 on diabetes risk within cohorts with normal and increased glucose levels at baseline. This evidence concerns the gene SERPINE1 and type 2 diabetes mellitus.